Early Treatment>14 years & above:4capsules x 3 times a day ( after breakfast, lunch and dinner) for7 to 10 days. To systematically determine the effect of Lianhua Qingwen Capsules on the early antiviral and anti-inflammatory action against COVID-19 (Coronavirus 2019) and its applicational value in the treatment of COVID-19. Yizhu Wang, Hongtao Wang, Xue Han, et al. You may be trying to access this site from a secured browser on the server. Egger M, Davey Smith G, Schneider M, et al. It has a wide-spectrum antiviral, effective antibacterial, antipyretic and anti-inflammatory, antitussive and expectorant, immune-regulating and other systemic intervention functions,[1625] especially for the coronavirus SARS[26] And Middle East respiratory syndrome (MERS)[27] have significant inhibitory and killing effects. We will use the formal test for subgroup interactions in Review Manager 5.3. Statistical analysis was conducted by Revman 5.3 software. Novel coronavirus pneumonia treatment plan issued by the national health and Health Committee, State Administration of traditional Chinese medicine (trial version sixth) [EB/OL]. Ephedra increases heartbeat and blood pressure. She can be reached atbandiolateresamayb@gmail.com. 2020 Jul 24;99(30):e21404. According to the Cochrane Handbook bias risk assessment tool, bias risk is independently assessed. It is based on the published clinical research literature at present stage. 2.Its not appropriate to take nourishing chinese medicine wihte taking medicine. 4.Patients with diabetes patients,high blood pressure, heart diseases, liver disease, kidney disease and other severe chronic diseases shall take medicine under guidance of physician. National Health and Family Planning Commission of the people's Republic of China. Lianhua Qingwen Capsules can significantly improve the total effective rate for COVID-19 patients, as well as shorten the hospital stay and treatment time, which is worth of promotion in the clinic. [33] Previous pharmacodynamic studies have confirmed that Lianhua Qingwen capsule can significantly inhibit the SARS CoV virus in cultured cells in vitro, and has a significant inhibitory effect on H1N1, H3N2, h7n9, and other influenza viruses,[3436] indicating that Lianhua Qingwen capsule has played an important role in the prevention and control of public health events of respiratory system caused by virus. A: Chest radiograph of normal people; B: Chest radiograph of a. Unable to load your collection due to an error, Unable to load your delegates due to an error. We aim to assess the efficacy and safety of Lianhua Qingwen combined with Conventional antiviral Western Medicine in Clinical treatment of COVID-19 or asymptomatic infection. Nausea, diarrhea, vomiting, abdominal pain, dry mouth, rash, itching, dizziness. Avoid receiving nourishing Chinese medicine during the period in this product. Lianhua Qingwen formula is based on the theory of collateral disease, to reveal the law of transmission of respiratory infectious diseases caused by virus. Bias in. Nevertheless, this systematic view should help further expand our understanding of Lianhua Qingwen combined with conventional antiviral Western Medicine treatments in COVID-19 and asymptomatic infection. WebFor patients showing mild symptoms, Lianhua Qingwen would be more effective. Chinese Journal of pharmacology and toxicology 2015;29:2137. Individuals w/ cold deficiencies in spleen & stomach or w/ qi. Fish catch in Guimaras decreased by 29.6 percent from 7,844.53 metric tons in 2021 to 5,517 metric tons in 2022, as reported by the Chinese supplement Lianhua Qingwen: What you need to know, LOOK FOR BACKUP POWER: MORE Power assures 100% supply after weekend, Marcos prods NGCP to address energy woes in Western Visayas, Remains of two persons found dumped in concrete pipe, Guimaras fish yield down by 29.67% in 2022, DOE: Power reserves may run low in May, June, Globe secures ~P40.5B from its P91-B tower sale and leaseback, USTR keeps PH out of watchlist for 10 years, cites best, Iloilo taekwondo team hailed as overall champions in 2023 WVRAA meet, Gilas Pilipinas frontcourt woes continue as Aguilar & Erram ruled out, Kaya FC-Iloilo demolishes Mendiola FC in PFL clash, NBA Playoffs: Currys record-breaking 50-point Game 7 leads Warriors past Kings, Record-high 11,013 Filipino nurses took U.S. licensure exam for the first, Expert advice on identifying and treating allergic asthma, WHO and IAPAC sign a memorandum of understanding focused on ending, WHO launches new initiative to improve pandemic preparedness, 90% of countries report disruptions to essential health services since COVID-19 pandemic, Record-high 11,013 Filipino nurses took U.S. licensure exam for the first time in Q1, WHO and IAPAC sign a memorandum of understanding focused on ending epidemics in cities. Correspondence: Mingjun Liu, and Xiaolin Zhang, professor, Changchun University of Chinese Medicine, 1035 Boshuo Road, Jingyue Economic Development Zone, Changchun City, Jilin Province 130117, China (e-mail: [emailprotected], [emailprotected]). The following electronic bibliographic databases will be searched to identify relevant studies: CNKI, CBM, VIP and Wanfang databases, PubMed, EMBASE, MEDLINE, Cochrane central, and clinical trial registration centers, such as China Clinical Trial Registration Center (ChiCTR), Netherlands National Trial Registration Center (NTR) and clinical trials.gov. STATA15.1 and RevMan5.3 software were used to analyze meta outcomes of different intervention measures for the treatment of new crown pneumonia and the control group (conventional antiviral western medicine treatment) clinical efficacy. WebAs chemical analysis for quality control (QC) of traditional Chinese medicine (TCM) formula is difficult to guarantee the effectiveness, a bioassay method that combines QC with evaluation of therapeutic effects has been developed to assess the TCM quality. Press the space key then arrow keys to make a selection. For the treatment, the main effects of Lianhua Qingwen Jiaonang capsule are as follows: First, WebDrug Name Lianhua Qingwen Capsules; Approval No. GYZZ Z20040063; Strength 0.35g/capsule; Administration and Dosage For oral administration, 4 capsules once, 3 Though no specific drug has been developed so far, emerging agents have been confirmed effective or potentially beneficial to restrain it. After determining how to combine different types of studies, NRIs use the method of inverse variance of random-effect model to evaluate and calculate the 95% CI of the effect value. The protocol will be disseminated in a peer-reviewed journal or presented at a relevant conference. There are an increasing number of studies on for COVID-19 published with inconclusive results in recent. 8.Three days without any remission,or symptems aggravated,appeared new serious symptems, should go to hospital. Chest radiographs. PRISMA flow diagram of study and exclusion. National Key New Product Lianhua Qingwen capsule (granule) is an Innovative Patent Chinese medicine for the treatment of influenza, which was developed by the green channel of the new drug approval during the SARS period in 2003 based on the pathology of collateral of traditional Chinese medicine. World Healthy Organization. Journal of Guangzhou University of traditional Chinese medicine, 2016 33:5404. Avoid prolonged use. DC and QZ developed the search strategy. SHI JIA ZHUANG YI LING PHARMACEUTICAL CO.,LTD. Chinese Journal of experimental pharmacology 2015;21:13943. The course of treatment is 7-10 days for patients with mild and moderate COVID-19. It is also for prevention of low blood pressure during anesthesia. BMC Complement Altern Med 2017;17:130. The novel coronavirus pneumonia (COVID-19) has spread to >200 countries and regions. However, this systematic review will have some limitations. Just because a supplement is derived from natural sources does not mean it is safe. This product should not be used in treatment of wind-cold. The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function[J]. Choosing a selection results in a full page refresh. In 2010, Diagnosis and Treatment Scheme for Wind-warm Lung-heat Disease (Non-severe Community Acquired Pneumonia) (2010), issued by the Chinese Health Protection Committee and the State Administration of Traditional Chinese Medicine 2020 Sep 11;15(9):e0238828. The assessment will be adjudicated into 4 levels: high, moderate, low, or very low. Clinically, Lianhua Qingwen Capsule can be used in the treatment of cold, flu-induced bronchitis, pneumonia, COPD, interstitial pneumonia and other lung inflammation. How to Use: Dosage: Consume orally 4 capsules each, 3 times daily after meal. In 2009, Diagnosis and Treatment Scheme for Patients Infected with Type A H1N1 Influenza (2009), issued by the State Administration of traditional Chinese medicine Records from databases and other resources will be uploaded to a database created by EndNote9.7 software. Race to find. The studies that do not fulfill the inclusion criteria will be excluded and listed with reasons for their exclusion. [1] Over 200 countries and regions in the world have reported the confirmed cases successively, and become the global fast spread pandemic. Wolters Kluwer Health It is reported that the registration number of Lianhua Qingwen Capsules in the Philippines is THPR-50 and the product category is traditional herbal drugs. Higgins JPT, Thompson SG, Deeks JJ, et al. Dont take this medicine if the description has changed. This product should be administered strictly in accordance with dosage and administration, and is not for long-term use. In 2008, Diagnosis and Treatment Scheme for Patients Infected with Avian Influenza (2008), issued by the Ministry of Health The capsule is hugely popular and controversial as it traces its roots to a prescription that date back to classic medical texts written during the Han dynasty (206BC220AD), according to a report from the South China Morning Post. Consult with doctors or pharmacists before administration if other medicines are received during this time. PMC Coronavirus disease 2019 (, [5]. [24]. WebDosage: 2 capsules twice a day ( after breakfast & dinner) >14 years & above: 4 capsules x 3 times a day ( after breakfast, lunch and dinner) for 7 to 10 days. 2023 Feb 17;2023:6028554. doi: 10.1155/2023/6028554. Patients with hypertension or heart disease should use with caution, patients with chronic disease such as diabetes, liver disease, kidney disease should take medicine under doctors direction. All relevant data are within the article and its supporting information files. Among the many commonly used TCMs, the most commonly used one is Lian-Hua Qing-Wen Granule (LHQWG). The results will be cross-checked by the 2 reviewers, and any disagreements will be resolved by consensus, with any ongoing differences in opinion being arbitrated by a third reviewer (LMJ). It is not necessary for ethical approval because this article is based on previously conducted studies and does not involve any new studies of human or animal subjects performed by any of the authors. In addition, we learned from the experience of Rhubarb in the treatise on Febrile Diseases in the treatment of epidemic diseases. Please try again soon. Delivery takes 2 business days & another 2 calendar days for order processingPROMO OFFER ( completed & over) : Buy 1 Bundle, We Donate 1 Bundle ! Lianhua Qingwen (LHQW) Asia's one-stop resource for medical news, clinical reference and education, Philippine Archipelago International Trading, Click to view Lianhua Qingwen detailed prescribing information. < 5 years: not recommended because it may be difficult for young children to swallow capsules. LHQWG was first used in the treatment of influenza, and studies have found that the drug is superior to oseltamivir in improving the symptoms of influenza A virus infection. Also illustrates the potential biases within each of the included studies by presenting a risk of bias," table, graph, and summary. WebDosage/Direction for Use 4 cap tid w/ warm water. One box of LHQW last 2 days and 4 boxes last 8 days. Chinese herbal medicine 2008;31:12303. In addition, it can also interact with other compounds and herbs. First case of 2019 novel coronavirus in the United States. TheChinese researchers also claim thatLHQWisa classical Chinese medical preparation and that itscapsules or granulesareconsist of 11 herbs, gypsum,and mentholwhich are recorded in the2015 Edition ofthe ChinesePharmacopoeia. [29]. 15. All randomized controlled trials (RCTs), Retrospective cohort study (RCSs), Comparison before and after the study (BAs) of Lianhua Qingwen combined with Conventional antiviral Western Medicine for COVID-19 will be included. Is there any notice for taking Lianhua Qingwen Capsules? 4. patients: total number and number in both groups, baseline characteristics, diagnostic criteria, withdrawals, and losses to follow-up (reasons, description); 5. outcomes: outcomes specified above, adverse drug reactions, and adverse time, length of follow-up, quality of reporting of outcomes. The https:// ensures that you are connecting to the Sign in to listen to groundbreaking journalism. Put this medicine beyond the childrens reach. Hongying Mo, Zifeng Yang, Jinping Zheng, et al. Asia's one-stop resource for medical news, clinical reference and education, Click to view Lianhua Qingwen detailed prescribing information. Effectiveness and Safety of Lianhua Qingwen Capsules for COVID-19: A Propensity-Score Matched Cohort Study. (For Children 4 to 18 years of age): 3 times daily. The COVID-19 may improve the clinical symptoms associated with fever, cough, and fatigue. may email you for journal alerts and information, but is committed You may search for similar articles that contain these same keywords or you may Because the epidemic situation is still ongoing, there are still clinical studies in progress. Also excluded are studies enrolling <30 participants. 1. Part of the goods frequent replacement of packaging, such as goods and pictures are not exactly the same, please refer to the goods you receive. N Engl J Med 2020;382:92936. Particularly, when ephedrine is combined with caffeine (coffee), itcan lead to significant cardiovascular, metabolic, and hormonal responses. FOIA Bookshelf Biotechnology communication 2003;14:3902. [8]. Meta-analysis on the effect of combining Lianhua Qingwen with Western medicine to treat coronavirus disease 2019. However, there are individual differences in the efficacy of traditional Chinese medicine compound Lianhua Qingwen, which makes the quality of evidence of clinical efficacy of traditional Chinese medicine low. The two groups were compared in terms of clinical effects and main symptom (fever, cough and fatigue) disappearance rate. In 2018, Diagnosis and Treatment Scheme for Influenza (2018), issued by the National Health and Family Planning Commission "It's the first time in the world that we have enough evidence to prove Lianhua Qingwen Jiaonang capsule is effective and can help patients recover," Zhong said, adding they have just finished an experiment and the results are promising and werepublished. AChinese researchclaimsthat ithas been used for viral infections for more than a decade, includingSevere Acute Respiratory Syndrome (SARS)in 20022003. Writing original draft: Xiaolin Zhang, Di Cao. Disclaimer. FDA Phase-II Clinical Study, In 2020, Diagnosis and Treatment Scheme for Novel Coronavirus Pneumonia, jointly issued by the Chinese Health Protection Committee and the State Administration of Traditional Chinese Medicine Select all eligible studies published before May 8, 2020. Learn more. 7. In China, lianhua qingwen is recommended for treating thepneumonia. Dosage: 2 capsules twice a day ( after breakfast & dinner). Click to view Lianhua Qingwen detailed prescribing information Overdosage View Lianhua Qingwen [Manufacturer]Company name: Shijiazhuang Yiling Pharmaceutical Co., Ltd. For oral use after meals,4 capsules thrice daily or by medical ordor5 boxes for a treatment course. Second, CT scan result also shows that patients recover faster than the control group. WebLianhua Qingwen Dosage & Drug Information | MIMS Thailand Lianhua Qingwen(Forsythiae fructus 225 mg, Lonicerae japonicae flos 225 mg, Ephedrae herba If I2 test <50%, a fixed-effects model will be used to pool the data. Published by Wolters Kluwer Health, Inc. 1. general information: title, authors, year of publication, and Study area, average age, average course of disease and treatment time; 2. trial characteristics: design, duration of follow-up, method of randomization, allocation concealment, incomplete outcome data, blinding (patients, people administering treatment, outcome assessors); 3. intervention(s): intervention(s) (The dosage form of. Conclusion: cDepartment of lung diseases, the Third Clinical Hospital of Changchun University of Chinese Medicine, Changchun, Jilin, China. Novel coronavirus pneumonia treatment plan (revised version 7) [EB/OL]. For the treatment of COVID-19, the main effects of Lianhua Qingwen are as follows: First, after taking the capsule, patients' symptoms improve quickly, two days earlier than the control group. Second, CT scan result also shows that patients recover faster than the control group. Third, the capsule can shorten fever time. Shunya Zhu, Xiaoying Li, Yunling Wei, et al. When you buyLHQW from us, actsmarket.com will donate the same number of boxes to needy seniors above 50 years old, living in 1-room or 2-room rental flats in Singapore, cap at 140 bundles or 700 boxes. Placebo, routine western medicine therapy, and other therapeutic methods in the comparators (drugs, dose, frequency, duration); (5) Outcomes: the primary outcomes include total efficiency, primary symptoms, and Why is it important to subscribe? 2022 Jan;20(1):26-33. doi: 10.1016/j.joim.2021.10.005. Study on the anti Staphylococcus aureus biofilm formation of Lianhuaqingwen capsule [J]. [30] The I2 statistic of <50% indicates a low level of statistical heterogeneity, and that of 50% will be considered substantial statistical heterogeneity. China's top respiratory expert, the leader of the high-level expert group of the National Health Commission, Zhong Nanshan said in a webinar with overseas Chinese students, Lianhua Qingwen capsule has been proven effective for the treatment of virus. If I2 test 50%, a random-effects model will be used for data analysis instead. Measuring inconsistency in meta-analyses. The site is secure. Please be informed that only the The treatment strategy of active intervention is put forward, which includes the treatment of both exterior and interior, the treatment of syndrome first, the treatment of disease cutting off, the overall adjustment, and multitarget treatment. LHQW won the 2nd prize of the National Scientific and Technological Progress Award in 2011 for the treatment of influenza. Buy more and get more. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. All reports of the randomized controlled trials (RCTs) on Lianhua Qingwen capsule treating influenza The Authors. Ephedra was banned from the Olympics and other sport events, even in the US military. In the analysis, we will exclude lower-quality trials and repeat the meta-analyses to examine whether the quality of included studies influences the pooled results. Below dosage is a guide only. Writing review & editing: Xiaolin Zhang. Data is temporarily unavailable. All the prescriptions are used to clear the toxic heat in the lung, clear the lung qi, and cut off the disease. The secondary outcomes of this review will include antipyretic time, disappearance rate of fever symptoms, disappearance rate of cough symptoms, disappearance rate of asthenia symptoms, and adverse drug events. To add, theonline sale and distribution ofthis productis prohibited and those engaging in this activityviolatethe R.A.10918orPhilippine Pharmacy Act. As stated in the research paper published on "Scientific World Journal", Lianhua-Qingwen capsule (LQC) is a commonly used Chinese medical preparation to treat virus and especially played a very important role in the fight against severe acute respiratory syndrome (S-A-R-S) in 2002-2003 in China. Lianhua Qingwen was developed by Shijiazhuang Yiling Pharmaceutical in 2003 as a treatment for severe acute respiratory syndrome (SARS) following the outbreak of the disease in 2002 and was listed by the National Health Commission of China in 2004 as a treatment for influenza and other respiratory disease. The capsule was earlier developed in 2003 to treat the severe acute respiratory syndrome (SARS) and extracts the essence of 13 herbs. Copyright 2023 MIMS Pte Ltd. All rights reserved. Sofia Tomacruz covers defense and foreign affairs. It is to systematically understand the curative effect of Lianhua Qingwen on the treatment of new crown pneumonia, and provide a reference for the design and follow-up work of the Chinese medicine compound Lianhua Qingwen in the global epidemic prevention and clinical trial design and follow-up work. Results: Designed by ACTSmarket. Domingo said this version of the capsule was still unregistered to date, meaning the FDA could not guarantee its quality and safety. Pharmacology and clinical research of traditional Chinese medicine 2010;26:214. Data curation: Xiaolin Zhang, Di Cao, Qi Zhang, Junnan Liu. Chinese Journal of viral diseases 2015;5:3524. In comparison with the control group, 1) the total effective rate was significantly higher in the observation group (P<0.05); 2) the disappearance rates of fever, cough and fatigue were statistically higher in the observation group; 3) the treatment time was significantly shorter and patient recovery was significantly better in the observation group; 4) the laboratory index levels [white blood cell (WBC), interleukin-6 (IL-6), serum amyloid A (SAA)] were better in the observation group. A trial of lopinavirritonavir in adults hospitalized with severe. This study will provide a relatively high-quality synthesis of current evidence of Lianhua Qingwen combined with Conventional antiviral Western Medicine in the treatment of COVID-19 from several aspects including the Clinical effective rate, CT improvement rate, severe conversion rate, antipyretic time, disappearance rate of fever symptoms, 11. Clipboard, Search History, and several other advanced features are temporarily unavailable. Objective: 1. It includes forsythia, honeysuckle, ephedra (ma huang), armeniacae, gypsum, isatis, dryopteridis, houttuynia, pogostemon, rheum, rhodiola, Chinese peppermint (bohe), and liquorice. [Adverse Reactions]Post-marketing monitoring data show that this product may cause gastrointestinal adverse reactions such as nausea, vomiting, abdominal pain, diarrhea, bloating, as well as rash, itchy ulcers, dry mouth, dizziness. See this image and copyright information in PMC. [Overview of Meta-analysis of Lianhua Qingwen preparations in treatment of viral diseases]. In addition, Manual retrieval of articles, conference papers, ongoing experiments, internal reports, among others, to supplement electronic retrieval. Les capsules Lianhua Qingwen sont les produits phares de Yiling Pharmaceutical pour le traitement de maladies spcifiques comme le rhume, la grippe et la COVID-19. Here are links to the publications that published the results of the clinical trial :https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229744/https://en.prnasia.com/releases/global/tcm-lianhua-qingwen-shows-stable-in-vitro-antiviral-effect-on-the-delta-variant-expert-327965.shtmlIngredients & ContradicationsPlease refer to the pictures for more informationUSAGE FOR RESPIRATORY DISEASES SUCH AS FLUS AND COLDSProphylaxis: If you know you are going out, take LHQW the day before, the day of the outing and the day after the outing. Get new journal Tables of Contents sent right to your email inbox, http://creativecommons.org/licenses/by/4.0, Http://www.nhc.gov.cn/jkj/s7916/202001/44a3b8245e8049d2837a4f27529cd386.sht-ml, https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-, http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd. Molecules. Exclusion: studies using two or more Chinese herbal compound as intervention measures will be excluded. In 2017, Diagnosis and Treatment Scheme for Patients Infected with H7N9 Avian Influenza (Version 1)(2017) , issued by the National Health and Family Planning Commission Lianhua Qingwen combined with conventional drugs may be a promising therapy for treating common pneumonia and COVID-19 pneumonia. Used in treatment of epidemic influenza and lung heat, symptom as fever or high fever, aversion to cold, muscular soreness, rhinostegnosis and nasal discharge, cough, headache, dry and sore throat, flushing tongue, or greasy fur of tongue. High heterogeneity may also arise from the various evaluations. Clinical observation shows that the total effective rate of traditional Chinese medicine is >90%.[15]. For the treatment, the main effects of Lianhua Qingwen Jiaonang capsuleare as follows: First, after taking the capsule, patients' symptoms improve quickly, recovery rate up to 91.5%, conversion to severe cases down to 2.1%. 94d329df351d7da8aefc2.shtml, https: //www.who.int/docs/default source/coronaviruse/situation-reports/20200325-sitrep-65-, https://www.jiyinzaixian.com/news/bNu5eb13ba6806e0, http://www.xinhuanet.com/politics/2020-03/24/c_1125757251.htm, http://www.nhc.gov.cn/yzygj/s7652m/202003/a31191442e29474b98bfed5579d5af95.shtml. Middle East respiratory syndrome case diagnosis and treatment program (2015 Edition) [J]. Consultancy by Fixx Digital [28]. Treatment of Pediatric Diseases, 2017, recognized as a recommended product in the Standard Therapy for Human Beings Infected by H7N9 Avian Influenza, 2016, the Phase II Clinical Trial for Lianhua Qingwen approved by US FDA started in Virginia in the US in September, 2015, recognized as a recommended product in the Expert Consensus Document on Treatment of Cold in Special Populations, 2015, recognized as a recommended product in the Standard Therapy for Middle East Respiratory Syndrome, 2014, recognized as a recommended product in the Standard TCM Therapy for Ebola Virus Infections, 2014, recognized as a recommended product in the Standard Therapy for Human Beings Infected by H7N9 Avian Influenza, 2013, recognized as a recommended product in the Expert Consensus Document on Medical Rescuing of Human Beings Infected by H7N9 Avian Influenza, 2013, recognized as a recommended product in the Standard Therapy for Human Beings Infected by H7N9 Avian Influenza, 2012, recognized as a recommended product in the Standard TCM Therapy for Influenza B Virus Infections, 2011, recognized as a recommended product in the Guideline on Diagnosis and Treatment of Influenza, 2010, recognized as a recommended product in the Standard Therapy for Rheumatic Fever (Non-severe Community Acquired Pneumonia), 2009, recognized as a recommended product in the Standard Therapy for Human Beings Infected by Influenza A H1N1, 2008, recognized as a recommended product in the Instructions on Use of TCM Therapies for Prevention and Treatment of Diseases after an Earthquake, 2008, recognized as a recommended product in the Standard Therapy for Human Beings Infected by Avian Influenza (2008), 2005, recognized as a recommended product in the Standard Therapy for Human Beings Infected by Avian Influenza, [Drug Name]Generic name: Lianhua Qingwen Capsules. In particular, theChinese herbma huang, scientifically known asEphedra sinica, is where the drug ephedrine is extracted from. BMJ 2008;336:9246. National Bureau of disease control and prevention. The abstracts of all studies will be independently screened by the review authors (XLZand QL). WebTo evaluate the efficacy and safety of Lianhua Qingwen capsule for influenza. Lianhuaqingwen (LHQW) has anti-inflammatory and immune regulatory functions and may inhibit the airway inflammation that occurs during an acute exacerbation of COPD. Also,its packaging is in Chinese characters and needs to comply with FDAs labeling requirements written in English. The 3 drugs and 3 parties in China have been effective in many countries around the world, and once again reveal the special advantages of the Chinese herbal medicine overall adjustment and multi target therapy, which suggests the application of Lianhua Qingwen granule. The patients receiving Lianhua Qingwen Capsule treatment were assigned to the observation group (n=33) and those given conventional therapy were included in the control group (n=33). government site.